🧠 Addiction and depression: untangling cause and effect ✨

The majority of people who present to Australian AOD services also meet criteria for depression. For decades they were treated as two separate problems by two separate services. The current evidence is unambiguous: integrated treatment of both conditions, by the same team, at the same time, produces meaningfully better outcomes than treating either one alone.

Two conditions, often one biology

Depression and substance use disorders share substantial biological territory. Both involve dysregulation of dopamine and serotonin systems. Both produce changes in the brain's reward circuitry that make ordinary pleasures feel muted. Both are characterised by a flattening of motivation and a narrowing of life. Heavy alcohol use, in particular, is itself a depressant — and almost everyone who drinks heavily for years will at some point experience clinically significant low mood, regardless of whether they had a primary depressive disorder to begin with.

This shared territory is why disentangling cause and effect is so hard, and why "which came first?" is often the wrong question. The right question is "what does this person need to recover from each condition, and how do we deliver both at once?"

Substance-induced low mood vs primary depression

Clinically, the distinction matters because it changes the treatment plan.

Substance-induced depressive episode — low mood that arises during, or shortly after, sustained heavy use of a depressant (most commonly alcohol, but also benzodiazepines, cannabis in some users, and opioids). Tends to lift substantially with four to eight weeks of abstinence. Does not always need antidepressant medication.

Primary depressive disorder with co-occurring substance use — low mood that pre-dated the heavy use, or that persists at clinically meaningful levels well beyond the period in which substance-induced low mood would normally lift. Requires treatment in its own right.

The honest clinical reality is that you often cannot tell which you are dealing with until the person has been off the substance for four to six weeks. Many people experience a meaningful lift in mood during that period — and that itself is diagnostically useful information.

The "self-medication" framing — useful, but limited

People often describe their drinking or drug use as "self-medication" for depression. The framing has truth in it: many people do begin using to mute psychological pain. But the framing is also misleading, because the substances most commonly used in this way — alcohol, cannabis, opioids — almost always make depression worse over time, by disrupting sleep, isolating the user socially, eroding their job and relationships, and biologically deepening the very mood they are trying to lift.

A useful reframing in treatment: yes, you started using to feel better. That was an understandable response to real pain. The problem is that the medicine you chose works for two hours and breaks you for forty-eight. Recovery is, in part, finding medicine that actually works.

What integrated treatment looks like in Australia

Concretely, integrated treatment for co-occurring depression and substance use usually involves:

• A treatment plan that names both conditions explicitly and sets goals for each.
• Pharmacotherapy that takes both into account — typically an SSRI (sertraline and escitalopram are first-line in Australia), often started early rather than waiting for "stable sobriety" before assessing.
• Psychological treatment, usually CBT or behavioural activation, that interweaves modules for both conditions.
• Concurrent treatment of any AOD-specific pharmacotherapy needed (naltrexone, acamprosate, opioid pharmacotherapy).
• Active management of suicide risk — this matters because the combination of depression and substance use carries higher suicide risk than either condition alone.

Antidepressants and alcohol

Three points worth knowing.

First, the older view that antidepressants "do not work" if a person is still drinking was based on weaker evidence than is sometimes claimed. Current Australian guidelines (RACGP and the National Comorbidity Guidelines) generally support starting an SSRI in a person with both conditions, even before sustained sobriety, particularly where depression is severe.

Second, alcohol does interfere with antidepressant effectiveness — partly because it is itself a depressant, partly because heavy drinking disrupts sleep, which is the foundation of mood. Treatment will work better if drinking is reduced, but treatment can begin before drinking is fully addressed.

Third, there are specific drug interactions to watch for. SSRIs combined with heavy alcohol use raise the risk of falls, gastrointestinal bleeding, and serotonin syndrome (rare). Mirtazapine — sometimes useful for depression with insomnia — has its own sedation profile that compounds with alcohol. These are clinical-decision questions for a GP or psychiatrist, not reasons to avoid treatment.

Behavioural activation — the most under-used tool

For both depression and substance-use recovery, behavioural activation has remarkably good evidence. The simple version: get the person doing things that, in their pre-depressed life, produced satisfaction or competence. Walking, fishing, music, gym, gardening, cooking, social contact. None of it sounds like "treatment" because it is so unspectacular. But the evidence base — across both depression and AOD literature — is large and consistent.

Why it matters here: depression and substance use both narrow life. The person sleeps later, sees fewer people, does less. The using both produces and worsens that narrowing. Behavioural activation reverses it deliberately, before mood has lifted, on the well-evidenced principle that mood follows behaviour as much as behaviour follows mood.

The suicide risk question

People with co-occurring depression and substance use have substantially higher rates of suicidal ideation and attempts than people with either condition alone. This is not a footnote — it is one of the central reasons integrated treatment matters. Practical implications: explicit safety planning early in treatment, removal of means where possible (firearms, large stockpiles of medication), and ready access to crisis support (Lifeline 13 11 14, Beyond Blue 1300 22 4636). Family members involved in care should know the warning signs and the numbers to call.

How long until you feel better

Realistic expectations.

Weeks 1 to 4 of sobriety: mood often dips before it improves. Sleep is fragmented. The first week off alcohol can feel worse than baseline. This is biologically expected.

Weeks 4 to 12: meaningful mood improvement for a substantial proportion of people, particularly those whose depression was largely substance-driven. SSRIs, if started, are reaching therapeutic effect in this window.

Months 3 to 12: if depression persists at clinically meaningful levels, this is when treatment for primary depression in earnest gets fully traction — adequate-dose antidepressant trials, structured psychotherapy, lifestyle interventions (exercise, sleep, sunlight).

A real, durable improvement in both conditions usually takes a year or more, sometimes longer. But the trajectory in integrated care is much better than in the old sequential model — which is the central point.

How to access integrated care in Australia

A GP appointment with a Mental Health Care Plan, naming both substance use and depression explicitly, is the right first step for almost everyone. The GP can refer to a psychologist with dual-diagnosis experience, prescribe an SSRI, and connect to a public AOD service. State alcohol and drug lines, public AOD intake services, headspace (for under-25s), and Beyond Blue's NewAccess all operate on a dual-diagnosis-aware model in 2026. Private addiction medicine specialists are another route, particularly where complexity is high — most also work with co-occurring depression as a matter of course.